Here, we extend those findings by demonstrating that cilastatin also protects against sepsis-induced AKI via interference with the TLR4/MyD88/NF-κB and NLRP3 signaling pathways, resulting in improved survival. The gene discussed is MYD88; the disease is acute kidney injury.